<DOC>
	<DOCNO>NCT02674152</DOCNO>
	<brief_summary>This Phase I , non-randomized , uncontrolled , open-label , dose escalate study BI 836880 administer intravenously . The eligible patient population patient advance solid tumour . At time trial , permit escalate dose fulfil escalation overdose control ( EWOC ) criterion</brief_summary>
	<brief_title>Dose Finding Study BI 836880 Patients With Solid Tumors</brief_title>
	<detailed_description />
	<criteria>Inclusion criterion : Age &gt; = 18 year Histologically cytologically confirm malignancy locally advance metastatic solid tumor , either refractory standard therapy disease standard therapy reliably effective , e.g . tolerate contraindication otherwise available standard therapy . ECOG performance status &lt; = 2 Adequate hepatic , renal bone marrow function Signed write informed consent . Life expectancy min . 3 month opinion investigator Recovery reversible adverse event previous anticancer therapy baseline CTCAE grade 1 , except alopecia ( grade ) sensory peripheral neuropathy CTCAE grade &lt; = 2 consider clinically significant . adequate contraception male female patient trial least 6 month end treatment . Exclusion criterion : Known hypersensitivity trial drug excipients Current prior treatment systemic anticancer therapy either within 28 day minimum 5 halflives , whichever short trial onset . Serious concomitant disease , especially affect compliance trial requirement consider relevant evaluation endpoint trial drug Major injury and/or surgery bone fracture within 4 week start treatment , plan surgical procedure trial period . patient personal family history QT prolongation and/or long QT syndrome , prolong QTcF baseline ( &gt; 470 m ) . QTcF calculate Investigator mean 3 ECGs take screening . Significant cardiovascular/cerebrovascular disease ( i.e . uncontrolled hypertension , unstable angina , history infarction within past 6 month , congestive heart failure &gt; NYHA II ) . Uncontrolled hypertension define : blood pressure rest relaxed condition &gt; =140 mmHg systolic , &gt; =90 mmHg diastolic ( without medication ) , measure accord protocol . History severe haemorrhagic thromboembolic event past 12 month ( exclude central venous catheter thrombosis peripheral deep vein thrombosis ) . Known inherited predisposition bleed thrombosis opinion investigator . Patient brain metastasis symptomatic and/or require therapy . Patients require fulldose anticoagulation ( accord local guideline ) . Active alcohol drug abuse opinion investigator . Patients judicial protection patient legally institutionalize . Patients unable unwilling comply protocol Women pregnant , nursing , plan become pregnant trial</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2017</verification_date>
</DOC>